 No Prescription Meds and Arthritis |
 |
 | ||
|
Intalith CR Eskalith |
|
| ||
No Prescription Meds and Arthritis » Prescription Drugs 9 » Intalith CR Eskalith Indications1.Treatment of mania and hypomania. 2.Lithium may also be tried in the treatment of some patients with recurrent bipolar depression for which treatment with other antidepressants has been unsuccessful. 3.Prophylactic treatment of recurrent affective disorders.Dosage and AdministrationA simple treatment schedule has been evolved which except for some minor variations should be followed whether using LITHICARB FC therapeutically or prophylactically. The minor variations to this schedule depend on the elements of the illness being treated and these are described later.1. In patients of average weight (70kg) an initial dose of 400- 1 200mg of LITHICARB FC may be given as a single daily dose in the morning or on retiring. Alternatively the dose may be divided and given morning and evening. The tablets should not be crushed chewed or swallowed with hot liquids. When changing from other lithium preparations serum lithium levels should first be checked then 2. LITHICARB FC therapy commenced at a daily dose as close as possible to the dose of the other form of lithium. As bioavailability varies from product to product (particularly with regard to retard or slow release preparations) a change of product should be regarded as initiation of new treatment. 3. Four to five days after starting treatment (and never longer than one week) a blood sample should be taken for the estimation of serum lithium level. 4. The objective is to adjust the LITHICARB FC dose so as to maintain the serum lithium level permanently within the diurnal range of 0.5 - 1.5 mmol/L. In practice the blood sample should be taken between 12 and 24 hours after the previous dose of LITHICARB FC. 'Target' serum lithium concentrations at 12 and 24 hours are shown in Table 1.LITHICARB FC tablets are scored therefore they can be divided accurately to provide dosage adjustments as small as 125mg. Serum lithium levels should be monitored weekly until stabilisation is achieved.Table 1. Target serum lithium concentrations "Target" serum lithium concentration (mmol/L) At 12 hours At 24 hours Once daily dosage 0.7 - 1.0 0.5 - 0.8 Twice daily dosage 0.5 - 0.8 4. Lithium therapy should not be initiated unless adequate facilities for routine monitoring of serum concentrations are available. Following stabilisation of serum lithium levels the period between subsequent estimations can be increased gradually but should not normally exceed three months. Additional measurements should be made following alteration of dosage on development of intercurrent disease signs of manic or depressive relapse following significant change in sodium or fluid intake or if signs of lithium toxicity occur. 5. Whilst a high proportion of acutely ill patients may respond within three to seven days of the commencement of LITHICARB FC therapy LITHICARB FC should be continued through any recurrence of the affective disturbance. This is important as the full prophylactic effect may not occur for 6 to 12 months after the initiation of therapy. 6. In patients who show a positive response to LITHICARB FC therapy treatment is likely to be long term. Careful clinical appraisal of the patient should be exercised throughout medication (see Precautions).Treatment of Acute Mania Hypomania and Recurrent Bipolar Depression:It is likely that a higher than normal LITHICARB FC intake may be necessary during an acute phase and divided doses would be required here. Therefore as soon as control of mania or depression is achieved the serum lithium level should be determined and it may be necessary dependent on the results to lower the dose of LITHICARB FC and re-stabilise serum lithium levels. In all other details the described treatment schedule is recommended.Prophylactic Treatment of Recurrent Affective DisordersIt is recommended that the described treatment schedule is followed.Use in the Elderly:In elderly patients or those below 50kg in weight it is recommended that the starting dose be 400mg. Elderly patients may be more sensitive to undesirable effects of lithium and may also require lower doses in order to maintain normal serum lithium levels. It follows therefore that long term patients often require a reduction in dosage over a period of years.Use in Children and AdolescentsNot recommended. Buy Intalith CR Eskalith and other Prescription Drugs 9 products online at Medstore. Buy Online at Medstore - Click Here!
About Intalith CR Eskalith: Product Type: Prescription Drugs 9 Intalith CR (Eskalith Generic Lithium Carbonate) Intalith CR (Eskalith Generic Lithium Carbonate) Eskalith Generic Lithium Carbonate 450mg 400(4 x 100) Tablets 200(2 x 100) Tablets 100 Tablets Eskalith Generic Lithium Carbonate Intalith CR
View more Prescription Drugs 9 No Prescription Meds and Arthritis: Arava (Leflunomide) Arava (Leflunomide) is a pyrimidine synthesis inhibitor used to treat rheumatoid arthritis. This medicine may be used to reduce the signs and symptoms of rheumatoid arthritis slow the development of damage to the joints and to improve physical function. Buy Arava (Leflunomide) and other Arthritis products online at Medstore. About Arava (Leflunomide): Product Type: Arthritis Brand name: Arava Generic name: Leflunomide What is the most important information I should know about Arava? • Arava is in the FDA pregnancy category X. There is an increased risk of birth defects and death of the unborn baby while taking Arava. Do not take this medication if you are pregnant or could become pregnant during treatment. Notify your doctor immediately if you think you have become pregnant during treatment. Birth control must be used during treatment with Arava. Discuss with your doctor the procedure for removing Arava from the body following treatment before becoming pregnant. Without the proper drug elimination procedure it may take up to two years before Arava is at sufficiently low levels in the body so as to reduce the risk of harm to an unborn baby. It is not known whether Arava imposes an increased risk of fetal harm when taken by a man. Men wishing to father a child while taking Arava should discuss their options with their doctor. What is Arava? • Arava affects the immune system and decreases inflammation. • Arava is used to reduce the signs and symptoms of rheumatoid arthritis reduce damage to the joints caused by rheumatoid arthritis and to improve physical function in people with rheumatoid arthritis. • Arava may also be used for purposes other than those listed in this medication guide. What should I discuss with my healthcare provider before taking Arava? • Before taking Arava tell your doctor if you have liver disease or a history of hepatitis; a history of significant alcohol use; kidney disease; an immune system disease; recently received a live vaccine; poor bone marrow function; or a current or chronic infection. • You may not be able to take Arava or you may require a dosage adjustment or special monitoring during your treatment if you have any of the conditions listed above. • Arava is in the FDA pregnancy category X. There is an increased risk of birth defects and death of the unborn baby while taking Arava. Do not take this medication if you are pregnant or could become pregnant during treatment. Notify your doctor immediately if you think you have become pregnant during treatment. Birth control must be used during treatment with Arava. Discuss with your doctor the procedure for removing Arava from the body following treatment before becoming pregnant. Without the proper drug elimination procedure it may take up to two years before Arava is at sufficiently low levels in the body so as to reduce the risk of harm to an unborn baby. It is not known whether Arava imposes an increased risk of fetal harm when taken by a man. Men wishing to father a child while taking Arava should discuss their options with their doctor. • It is not known whether Arava passes into breast milk. There is a potential for serious side effects in a nursing baby from Arava. Do not take Arava if you are breast-feeding a baby. How should I take Arava? • Take Arava exactly as directed by your doctor. If you do not understand these instructions ask your pharmacist nurse or doctor to explain them to you. • Take each dose with a full glass of water. • Arava can be taken with or without food or milk. • It is important to take Arava regularly to get the most benefit. • Your doctor may want you to have blood tests or other medical evaluations while taking Arava to monitor side effects and progress. • Store Arava at room temperature away from moisture and heat. What happens if I miss a dose? • Take the missed dose as soon as you remember. If it is almost time for your next dose skip the missed dose and only take your next regularly scheduled dose. Do not take a double dose of this medication unless otherwise directed by your doctor. What happens if I overdose? • Seek emergency medical attention if an overdose is suspected. • Symptoms of a Arava overdose may include diarrhea abdominal pain blood problems and liver problems. What should I avoid while taking Arava? • Discuss with your doctor the use of alcohol while taking Arava. Alcohol and Arava can both be damaging to the liver. • Arava can lower the activity of the immune system making you more susceptible to infection. Avoid contact with people who have colds the flu or other contagious illnesses. In addition do not receive vaccines that contain a live strain of the virus (e.g. live oral polio vaccine) and avoid contact with individuals who have recently been vaccinated with a live virus. What are the possible side effects of Arava? • If you experience any of the following serious side effects stop taking Arava and seek medical treatment or contact your doctor immediately: an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips tongue or face; or hives); changes in liver function (may be detected by blood tests or cause symptoms such as yellowing of the skin or eyes; pale colored stools or dark colored urine; unusual fatigue; or abdominal pain); decreased bone marrow function or blood problems (may be detected by blood tests or cause symptoms such as extreme or unusual fatigue; easy bruising or bleeding; black bloody or tarry stools; fever or chills; or signs of infection such as fever; chills or sore throat); or skin rash; or sores in the mouth. • Other less serious side effects may be more likely to occur. Continue to take Arava and talk to your doctor if you experience headache; increased blood pressure; muscle aches; nausea; diarrhea; or hair loss. • Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. What other drugs will affect Arava? • Before taking Arava tell your doctor if you are taking any of the following drugs: cholestyramine (Questran Prevalite LoCHOLEST); methotrexate (Rheumatrex); or rifampin (Rifadin Rimactane). • You may not be able to take Arava or you may require a dosage adjustment or special monitoring during treatment if you are taking any of the medicines listed above. • Drugs other than those listed here may also interact with Arava. Talk to your doctor and pharmacist before taking or using any other prescription or over-the-counter medicines including vitamins minerals and herbal products Generic Arava (Leflunomide) Lefumide Leflunomidum Lefunomide 10mg 120 pills 10mg 240 pills 10mg 60 pills 10mg 30 pills 10mg 90 pills Leflunomide Arava
| ||
